☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Four Year
Novartis Enters into a Four-Year Collaboration with Orionis Biosciences to Tackle Intractable Disease Targets
March 6, 2020
Sun Pharma Reports Four Years Result of Ilumya (tildrakizumab-asmn) in P-III reSURFACE 1 and 2 Trials in Patients with Moderate-to...
October 10, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.